| License: Creative Commons Attribution 4.0 (6MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-405687
- DOI to cite this document:
- 10.5283/epub.40568
Abstract
Pharmacological inhibition of the renin-angiotensin-aldosterone system (RAAS) is, in combination with diuretics, the first-choice treatment for hypertension, although 10-20% of patients do not respond adequately. Next to the RAAS, the nitric oxide/cGMP/protein kinase G (PKG) system is the second fundamental blood pressure regulator. Whether both systems influence each other is not well-studied. ...

Owner only: item control page